Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Theegarten

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
HNO|November 8, 2003
[Foudroyant rhinocerebral zygomycosis]H Sudhoff, M Wagner, D Theegarten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer stagingK Darwiche, P Zarogoulidis, K Baehner, et al.
Lung|August 31, 2022
Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of SarcoidosisJ Wälscher, E Büscher, F Bonella, et al.
Oncotargets and Therapy|November 25, 2014
Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analysesF Oezkan, Am Khan, P Zarogoulidis, et al.
Der Pathologe|December 25, 2012
[Glandular papilloma of the right main bronchus. Detection of an exon 2 mutation of the KRAS gene (c.35G>A)]J Wohlschläger, S Welter, G Stamatis, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 10, 2003
Idiopathic bronchiolitis mimicking diffuse panbronchiolitisVenerino Poletti, Marco Chilosi, Rocco Trisolini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionationC Pöttgen, W Eberhardt, B Graupner, et al.
British Journal of Cancer|February 11, 2015
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53R F H Walter, F D Mairinger, S Ting, et al.
Neuropathology and Applied Neurobiology|November 7, 2006
Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7U Rüb, E R Brunt, E Petrasch-Parwez, et al.
Plos One|June 1, 2018
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancerR F H Walter, P Rozynek, S Casjens, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
HNO|November 8, 2003
[Foudroyant rhinocerebral zygomycosis]H Sudhoff, M Wagner, D Theegarten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer stagingK Darwiche, P Zarogoulidis, K Baehner, et al.
Lung|August 31, 2022
Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of SarcoidosisJ Wälscher, E Büscher, F Bonella, et al.
Oncotargets and Therapy|November 25, 2014
Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analysesF Oezkan, Am Khan, P Zarogoulidis, et al.
Der Pathologe|December 25, 2012
[Glandular papilloma of the right main bronchus. Detection of an exon 2 mutation of the KRAS gene (c.35G>A)]J Wohlschläger, S Welter, G Stamatis, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 10, 2003
Idiopathic bronchiolitis mimicking diffuse panbronchiolitisVenerino Poletti, Marco Chilosi, Rocco Trisolini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionationC Pöttgen, W Eberhardt, B Graupner, et al.
British Journal of Cancer|February 11, 2015
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53R F H Walter, F D Mairinger, S Ting, et al.
Neuropathology and Applied Neurobiology|November 7, 2006
Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7U Rüb, E R Brunt, E Petrasch-Parwez, et al.
Plos One|June 1, 2018
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancerR F H Walter, P Rozynek, S Casjens, et al.
Pageof 7